Satish Tripathi
2022 ALI Fellow
Satish Tripathi brings to ALI deep experience developing new products in highly regulated industries. A senior biopharmaceutical leader, he has served on the executive teams of Avexis (Novartis), Iveric Bio, Roche-Genentech/Intermune, Johnson & Johnson, Syneos Health, Pfizer, and Baxter, leading R&D and business and global regulatory strategy in the development of new drugs, devices, and biologics. Satish is the founder of an education nonprofit, EK Kadam Aur, which provides a STEMbased college prep curriculum for high achieving high school students from low-income families in rural India and Nepal and offers participants an onramp to greater success in college and future entrepreneurial ventures. Ek Kadam Aur also offers digital learning platforms for visually impaired students.